Sakaki, Japan

Akira Ohno

This inventor holds 3 USPTO granted patents. Top assignee: Kotobuki Pharmaceutical Co Ltd. Active years: 2001-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akira Ohno. Retrieved from https://idiyas.com/inventor/akira-ohno-ndqgxn6h

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 66.7

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Sakaki-machi, JP (2001)
  • Nagano, JP (2006)

Company Filing History:


Years Active: 2001-2006

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Akira Ohno: Innovator in Pharmaceutical Chemistry

Introduction

Akira Ohno is a notable inventor based in Sakaki-machi, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds aimed at improving health outcomes.

Latest Patents

Ohno holds 3 patents, with his latest innovations focusing on the synthesis of β-lactam compounds. These compounds are designed for use as serum cholesterol-lowering agents. His work includes a detailed process for reproducing these compounds, which are represented by specific chemical formulas. Additionally, he has developed a method for preparing cycloheptimidazole compounds, showcasing his expertise in complex organic synthesis.

Career Highlights

Throughout his career, Akira Ohno has been associated with Kotobuki Pharmaceutical Co., Ltd., where he has played a pivotal role in advancing pharmaceutical research and development. His innovative approaches have contributed to the company's reputation in the industry.

Collaborations

Ohno has collaborated with several professionals in his field, including Tsuyoshi Tomiyama and Akira Tomiyama. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Akira Ohno's contributions to pharmaceutical chemistry through his patents and collaborative efforts highlight his importance as an inventor. His work continues to influence the development of effective health solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…